The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Role of STAT2 in the Alpha Interferon Signaling Pathway
Open accessAbstract
We have isolated U6A, a mutant cell line which lacks the STAT2 subunit of the transcription factor interferon (IFN)-stimulated gene factor 3 (ISGF3). The response of U6A cells to IFN-alpha is almost completely defective, but the response to IFN-gamma is normal. Complementation of U6A cells with a cDNA encoding STAT2 restores the IFN-alpha response, proving that STAT2 is required in this pathway. Binding of IFNs to their receptors triggers tyrosine phosphorylation and activation of the receptors, JAK family kinases, STAT1, and STAT2. In IFN-alpha-treated U6A cells, phosphorylation of the essential tyrosine kinases TYK2 and JAK1 is normal, but the phosphorylation of STAT1 is weak. A mutant STAT2 protein in which the phosphorylated tyrosine at position 690 is changed to phenylalanine does not restore normal phosphorylation of STAT1 in response to IFN-alpha. The dependence of STAT1 phosphorylation on the presence of STAT2 but not vice versa (T. Improta, C. Schindler, C. M. Horvath, I. M. Kerr, G. R. Stark, and J. E. Darnell, Jr., Proc. Natl. Acad. Sci. USA 91:4776-4780, 1994) indicates that in the formation of ISGF3, these two proteins may be phosphorylated sequentially in response to IFN-alpha and that phosphorylated STAT2 may be required to allow unphosphorylated STAT1 to bind to the activated IFN-alpha receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Self-citationCurrent protocols in molecular biology
(1988) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(88)90131-4 · Cited by 4,160
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070 · cited 3×
“Since phosphorylated STAT1 and STAT2 form a heterodimer (40, 51) and coprecipitate from extracts made from IFN-a-treated cells (39), this site might be the phosphotyrosine of STAT2 itself, as suggested by results showing that the phosphorylated tyrosine of STAT2 is required for STAT1 phosphorylation (Fig.”
BackgroundImproved retroviral vectors for gene transfer and expression.
Miller, A. D., & Rosman, G. J. (1989) · PubMed · Cited by 1,971
Kishimoto, T., Taga, T., & Akira, S. (1994) · Cell · doi:10.1016/0092-8674(94)90333-6 · Cited by 1,328
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899 · cited 2×
“Since phosphorylated STAT1 and STAT2 form a heterodimer (40, 51) and coprecipitate from extracts made from IFN-a-treated cells (39), this site might be the phosphotyrosine of STAT2 itself, as suggested by results showing that the phosphorylated tyrosine of STAT2 is required for STAT1 phosphorylation (Fig.”
BackgroundA protein tyrosine kinase in the interferon αβ signaling pathway
Velazquez, L., Fellous, M., Stark, G. R., & Pellegrini, S. (1992) · Cell · doi:10.1016/0092-8674(92)90105-l · Cited by 872
Self-citation
Cited by
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Ihle, J. N. (1995) · Nature · doi:10.1038/377591a0 · Cited by 1,203
Dendritic cell regulation of TH1-TH2 development
Moser, M., & Murphy, K. M. (2000) · Nature Immunology · doi:10.1038/79734 · Cited by 1,118
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Type I Interferons Keep Activated T Cells Alive
Marrack, P., Kappler, J., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 759
Karin, M., & Hunter, T. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00151-5 · Cited by 752
Cytokine Signaling Through Nonreceptor Protein Tyrosine Kinases
Taniguchi, T. (1995) · Science · doi:10.1126/science.7716517 · Cited by 692
Signaling and Transcription in T Helper Development
Murphy, K. M., Ouyang, W., Farrar, J. D., Yang, J., Ranganath, S., Asnagli, H., Afkarian, M., & Murphy, T. L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.451 · Cited by 633
Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α
Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andrea, A., & Livingston, D. M. (1996) · Nature · doi:10.1038/383344a0 · Cited by 493
A weak signal for strong responses: interferon-alpha/beta revisited
Taniguchi, T., & Takaoka, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073080 · Cited by 483
Immune Response in Stat2 Knockout Mice
Park, C., Li, S., Cha, E., & Schindler, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00077-7 · Cited by 415
Jaks, STATs, Cytokine Signal Transduction, and Immunoregulation: Are We There Yet?
O'Shea, J. J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80505-1 · Cited by 386
Manipulation of the Innate Immune Response by Varicella Zoster Virus
Gerada, C., Campbell, T. M., Kennedy, J. J., McSharry, B. P., Steain, M., Slobedman, B., & Abendroth, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00001 · Cited by 354
Gerhartz, C., Heesel, B., Sasse, J., Hemmann, U., Landgraf, C., Schneider-Mergener, J., Horn, F., Heinrich, P. C., & Graeve, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12991 · Cited by 307
Rodriguez, J. J., Parisien, J.-P., & Horvath, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11476-11483.2002 · Cited by 306
Greenlund, A. C., Morales, M. O., Viviano, B. L., Yan, H., Krolewski, J., & Schreiber, R. D. (1995) · Immunity · doi:10.1016/1074-7613(95)90012-8 · Cited by 304
Regulation of STAT‐dependent pathways by growth factors and cytokines
Leaman, D. W., Leung, S., Li, X., & Stark, G. R. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.14.9002549 · Cited by 297
Self-citationDumoutier, L., Tounsi, A., Michiels, T., Sommereyns, C., Kotenko, S. V., & Renauld, J.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404789200 · Cited by 291
Pellegrini, S., & Dusanter‐Fourt, I. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00615.x · Cited by 281
Structure of the Amino-Terminal Protein Interaction Domain of STAT-4
Vinkemeier, U., Moarefi, I., Darnell, J. E., & Kuriyan, J. (1998) · Science · doi:10.1126/science.279.5353.1048 · Cited by 270
Self-citationForero, A., Ozarkar, S., Li, H., Lee, C. H., Hemann, E. A., Nadjsombati, M. S., Hendricks, M. R., So, L., Green, R., Roy, C. N., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.07.007 · Cited by 265
Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression
Jones, M., Davidson, A., Hibbert, L., Gruenwald, P., Schlaak, J., Ball, S., Foster, G. R., & Jacobs, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5414-5420.2005 · Cited by 265
STAT2 deficiency and susceptibility to viral illness in humans
Hambleton, S., Goodbourn, S., Young, D. F., Dickinson, P., Mohamad, S. M. B., Valappil, M., McGovern, N., Cant, A. J., Hackett, S. J., Ghazal, P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220098110 · Cited by 255
Mutational analysis of acute-phase response factor/Stat3 activation and dimerization
Sasse, J., Hemmann, U., Schwartz, C., Schniertshauer, U., Heesel, B., Landgraf, C., Schneider-Mergener, J., Heinrich, P. C., & Horn, F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4677 · Cited by 120
“Carboxy-terminal domains of Stat1a and Stat2 are reported to be important for the transactivating potential of these factors (19, 24).”
BackgroundRole of the STAT1-SH2 Domain and STAT2 in the Activation and Nuclear Translocation of STAT1
Mowen, K., & David, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30073 · Cited by 53
Oladunni, F. S., Sarkar, S., Reedy, S., Balasuriya, U. B. R., Horohov, D. W., & Chambers, T. M. (2019) · Journal of Virology · doi:10.1128/jvi.01342-19 · Cited by 18
Metadata
- Authors
- Leung, S., Qureshi, S. A., Kerr, I. M., Darnell, J. E., & Stark, G. R.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1995-03
- Volume
- 15
- Issue
- 3
- Pages
- 1312-1317
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2151712105
- Cited by
- 279
- References
- 51
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.